NASDAQ

BIO-key International, Inc. (BKYI)

539 Thanks from members

BIO-key International, Inc. (BKYI) displays improving top-line revenue and significantly narrowed net losses for mid-2026, though persistent going concern warnings, low market capitalization, and a delayed hardware shipment weigh heavily on market sentiment and valuation stability.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →